NewAmsterdam grants 71,800 options at $24.16 to seven hires
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
NewAmsterdam Pharma (NAMS) has granted inducement share options for 71,800 ordinary shares to seven new non-executive hires, with an exercise price of $24.16 per share, matching the closing price on October 1, 2026. These options vest over four years. Additionally, 17,745 restricted stock units were granted to the same new hires, vesting in equal thirds over three years.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.